↓ Skip to main content

Dove Medical Press

Article Metrics

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase

Overview of attention for article published in Biologics: Targets & Therapy, December 2010
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
64 Mendeley
Title
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
Published in
Biologics: Targets & Therapy, December 2010
DOI 10.2147/btt.s5775
Pubmed ID
Authors

Tariq Mughal

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 2%
Japan 1 2%
United States 1 2%
Czechia 1 2%
Unknown 60 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 28%
Student > Master 12 19%
Researcher 7 11%
Student > Postgraduate 7 11%
Student > Ph. D. Student 6 9%
Other 6 9%
Unknown 8 13%
Readers by discipline Count As %
Medicine and Dentistry 18 28%
Biochemistry, Genetics and Molecular Biology 14 22%
Agricultural and Biological Sciences 10 16%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Chemistry 3 5%
Other 6 9%
Unknown 9 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2018.
All research outputs
#12,165,777
of 13,735,692 outputs
Outputs from Biologics: Targets & Therapy
#165
of 206 outputs
Outputs of similar age
#265,794
of 307,335 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 1 outputs
Altmetric has tracked 13,735,692 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 206 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,335 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them